National Bank Of Canada Oncolytics Biotech Inc Transaction History
National Bank Of Canada
- $90.1 Billion
- Q2 2025
A detailed history of National Bank Of Canada transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, National Bank Of Canada holds 24,664 shares of ONCY stock, worth $21,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,664
Previous 24,664
-0.0%
Holding current value
$21,211
Previous $18,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ONCY
# of Institutions
58Shares Held
1.41MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL207KShares$177,9340.01% of portfolio
-
Seeds Investor LLC New York, NY190KShares$163,3490.03% of portfolio
-
Goldman Sachs Group Inc New York, NY109KShares$93,8240.0% of portfolio
-
Royal Bank Of Canada Toronto, A667.1KShares$57,7140.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$57,5670.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $49.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...